Global Radiopharmaceuticals for Diagnosis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 127
Published Date: 30 Aug 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Diagnostic radiopharmaceuticals are a special class of drugs used in medical imaging diagnosis. These drugs contain radioactive isotopes that can locate and emit radiation signals in specific organs or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and extent of various diseases, such as cancer, heart disease, thyroid dysfunction, brain disease, etc.
According to our (Global Info Research) latest study, the global Radiopharmaceuticals for Diagnosis market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Radiopharmaceuticals for Diagnosis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Radiopharmaceuticals for Diagnosis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Radiopharmaceuticals for Diagnosis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Radiopharmaceuticals for Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Radiopharmaceuticals for Diagnosis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceuticals for Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceuticals for Diagnosis market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Atom High-tech Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Guangdong Xi'ai Pharmaceutical Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd., Chengdu Yunke Pharmaceutical Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Beijing Zhibo High-tech Biotechnology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Radiopharmaceuticals for Diagnosis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Technetium [99mTc] Dithiodithiocarbamate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Pentetate
Strontium [89Sr] Chloride
Iodine [125I] Sealed Seed Source
Sodium Iodide [131I]
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
Atom High-tech Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
Guangdong Xi'ai Pharmaceutical Co., Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
Chengdu Yunke Pharmaceutical Co., Ltd.
Shanghai Atom Kexing Pharmaceutical Co., Ltd.
Shenzhen Larven Bioengineering Technology Co., Ltd.
Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
Beijing Zhibo High-tech Biotechnology Co., Ltd.
Tianjin Said Biopharmaceutical Co., Ltd.
Chengdu Zhonghe Gaotong Isotope Co., Ltd.
Chengdu Xinke Pharmaceutical Co., Ltd.
Jubilant Radiopharma
PDRadiopharma Inc.
GE Healthcare Ltd
DOE IP
RadioMedix, Inc.
Lantheus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals for Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals for Diagnosis, with price, sales quantity, revenue, and global market share of Radiopharmaceuticals for Diagnosis from 2019 to 2024.
Chapter 3, the Radiopharmaceuticals for Diagnosis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals for Diagnosis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Radiopharmaceuticals for Diagnosis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals for Diagnosis.
Chapter 14 and 15, to describe Radiopharmaceuticals for Diagnosis sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Radiopharmaceuticals for Diagnosis Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Technetium 99mTc Dithiodithiocarbamate
1.3.3 Technetium 99mTc Polymerized Albumin
1.3.4 Technetium 99mTc Pentetate
1.3.5 Strontium 89Sr Chloride
1.3.6 Iodine 125I Sealed Seed Source
1.3.7 Sodium Iodide 131I
1.3.8 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Radiopharmaceuticals for Diagnosis Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Radiopharmaceuticals for Diagnosis Market Size & Forecast
1.5.1 Global Radiopharmaceuticals for Diagnosis Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Radiopharmaceuticals for Diagnosis Sales Quantity (2019-2030)
1.5.3 Global Radiopharmaceuticals for Diagnosis Average Price (2019-2030)
2.1 Atom High-tech Co., Ltd.
2.1.1 Atom High-tech Co., Ltd. Details
2.1.2 Atom High-tech Co., Ltd. Major Business
2.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Atom High-tech Co., Ltd. Recent Developments/Updates
2.2 Shanghai Xinke Pharmaceutical Co., Ltd.
2.2.1 Shanghai Xinke Pharmaceutical Co., Ltd. Details
2.2.2 Shanghai Xinke Pharmaceutical Co., Ltd. Major Business
2.2.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.2.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
2.3 Guangdong Xi'ai Pharmaceutical Co., Ltd.
2.3.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Details
2.3.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Major Business
2.3.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.3.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
2.4.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Details
2.4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Major Business
2.4.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product and Services
2.4.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments/Updates
2.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
2.5.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Details
2.5.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Major Business
2.5.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.5.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Chengdu Yunke Pharmaceutical Co., Ltd.
2.6.1 Chengdu Yunke Pharmaceutical Co., Ltd. Details
2.6.2 Chengdu Yunke Pharmaceutical Co., Ltd. Major Business
2.6.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.6.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments/Updates
2.7 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
2.7.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Details
2.7.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Major Business
2.7.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.7.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments/Updates
2.8 Shenzhen Larven Bioengineering Technology Co., Ltd.
2.8.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Details
2.8.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Major Business
2.8.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.8.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments/Updates
2.9 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
2.9.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Details
2.9.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Major Business
2.9.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.9.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
2.10 Beijing Zhibo High-tech Biotechnology Co., Ltd.
2.10.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Details
2.10.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Major Business
2.10.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.10.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments/Updates
2.11 Tianjin Said Biopharmaceutical Co., Ltd.
2.11.1 Tianjin Said Biopharmaceutical Co., Ltd. Details
2.11.2 Tianjin Said Biopharmaceutical Co., Ltd. Major Business
2.11.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.11.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
2.12.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Details
2.12.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Major Business
2.12.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.12.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments/Updates
2.13 Chengdu Xinke Pharmaceutical Co., Ltd.
2.13.1 Chengdu Xinke Pharmaceutical Co., Ltd. Details
2.13.2 Chengdu Xinke Pharmaceutical Co., Ltd. Major Business
2.13.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
2.13.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
2.14 Jubilant Radiopharma
2.14.1 Jubilant Radiopharma Details
2.14.2 Jubilant Radiopharma Major Business
2.14.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product and Services
2.14.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Jubilant Radiopharma Recent Developments/Updates
2.15 PDRadiopharma Inc.
2.15.1 PDRadiopharma Inc. Details
2.15.2 PDRadiopharma Inc. Major Business
2.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product and Services
2.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 PDRadiopharma Inc. Recent Developments/Updates
2.16 GE Healthcare Ltd
2.16.1 GE Healthcare Ltd Details
2.16.2 GE Healthcare Ltd Major Business
2.16.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product and Services
2.16.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 GE Healthcare Ltd Recent Developments/Updates
2.17 DOE IP
2.17.1 DOE IP Details
2.17.2 DOE IP Major Business
2.17.3 DOE IP Radiopharmaceuticals for Diagnosis Product and Services
2.17.4 DOE IP Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 DOE IP Recent Developments/Updates
2.18 RadioMedix, Inc.
2.18.1 RadioMedix, Inc. Details
2.18.2 RadioMedix, Inc. Major Business
2.18.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product and Services
2.18.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 RadioMedix, Inc. Recent Developments/Updates
2.19 Lantheus
2.19.1 Lantheus Details
2.19.2 Lantheus Major Business
2.19.3 Lantheus Radiopharmaceuticals for Diagnosis Product and Services
2.19.4 Lantheus Radiopharmaceuticals for Diagnosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Lantheus Recent Developments/Updates
3.1 Global Radiopharmaceuticals for Diagnosis Sales Quantity by Manufacturer (2019-2024)
3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturer (2019-2024)
3.3 Global Radiopharmaceuticals for Diagnosis Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Radiopharmaceuticals for Diagnosis by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Radiopharmaceuticals for Diagnosis Manufacturer Market Share in 2023
3.4.3 Top 6 Radiopharmaceuticals for Diagnosis Manufacturer Market Share in 2023
3.5 Radiopharmaceuticals for Diagnosis Market: Overall Company Footprint Analysis
3.5.1 Radiopharmaceuticals for Diagnosis Market: Region Footprint
3.5.2 Radiopharmaceuticals for Diagnosis Market: Company Product Type Footprint
3.5.3 Radiopharmaceuticals for Diagnosis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Radiopharmaceuticals for Diagnosis Market Size by Region
4.1.1 Global Radiopharmaceuticals for Diagnosis Sales Quantity by Region (2019-2030)
4.1.2 Global Radiopharmaceuticals for Diagnosis Consumption Value by Region (2019-2030)
4.1.3 Global Radiopharmaceuticals for Diagnosis Average Price by Region (2019-2030)
4.2 North America Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030)
4.3 Europe Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030)
4.4 Asia-Pacific Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030)
4.5 South America Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030)
4.6 Middle East & Africa Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030)
5.1 Global Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2030)
5.2 Global Radiopharmaceuticals for Diagnosis Consumption Value by Type (2019-2030)
5.3 Global Radiopharmaceuticals for Diagnosis Average Price by Type (2019-2030)
6.1 Global Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2030)
6.2 Global Radiopharmaceuticals for Diagnosis Consumption Value by Application (2019-2030)
6.3 Global Radiopharmaceuticals for Diagnosis Average Price by Application (2019-2030)
7.1 North America Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2030)
7.2 North America Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2030)
7.3 North America Radiopharmaceuticals for Diagnosis Market Size by Country
7.3.1 North America Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2030)
7.3.2 North America Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2030)
8.2 Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2030)
8.3 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
8.3.1 Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2030)
8.3.2 Europe Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2030)
10.2 South America Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2030)
10.3 South America Radiopharmaceuticals for Diagnosis Market Size by Country
10.3.1 South America Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2030)
10.3.2 South America Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Radiopharmaceuticals for Diagnosis Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Radiopharmaceuticals for Diagnosis Market Drivers
12.2 Radiopharmaceuticals for Diagnosis Market Restraints
12.3 Radiopharmaceuticals for Diagnosis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Radiopharmaceuticals for Diagnosis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Radiopharmaceuticals for Diagnosis
13.3 Radiopharmaceuticals for Diagnosis Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Radiopharmaceuticals for Diagnosis Typical Distributors
14.3 Radiopharmaceuticals for Diagnosis Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Radiopharmaceuticals for Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Radiopharmaceuticals for Diagnosis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Atom High-tech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Atom High-tech Co., Ltd. Major Business
Table 5. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 6. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Atom High-tech Co., Ltd. Recent Developments/Updates
Table 8. Shanghai Xinke Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Shanghai Xinke Pharmaceutical Co., Ltd. Major Business
Table 10. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 11. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 13. Guangdong Xi'ai Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Guangdong Xi'ai Pharmaceutical Co., Ltd. Major Business
Table 15. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 16. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 18. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 19. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Major Business
Table 20. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product and Services
Table 21. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments/Updates
Table 23. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Major Business
Table 25. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 26. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Chengdu Yunke Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Chengdu Yunke Pharmaceutical Co., Ltd. Major Business
Table 30. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 31. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 33. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Major Business
Table 35. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 36. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 38. Shenzhen Larven Bioengineering Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Shenzhen Larven Bioengineering Technology Co., Ltd. Major Business
Table 40. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 41. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments/Updates
Table 43. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Major Business
Table 45. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 46. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
Table 48. Beijing Zhibo High-tech Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Zhibo High-tech Biotechnology Co., Ltd. Major Business
Table 50. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 51. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments/Updates
Table 53. Tianjin Said Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Tianjin Said Biopharmaceutical Co., Ltd. Major Business
Table 55. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 56. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Major Business
Table 60. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 61. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments/Updates
Table 63. Chengdu Xinke Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Chengdu Xinke Pharmaceutical Co., Ltd. Major Business
Table 65. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product and Services
Table 66. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 68. Jubilant Radiopharma Basic Information, Manufacturing Base and Competitors
Table 69. Jubilant Radiopharma Major Business
Table 70. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product and Services
Table 71. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Jubilant Radiopharma Recent Developments/Updates
Table 73. PDRadiopharma Inc. Basic Information, Manufacturing Base and Competitors
Table 74. PDRadiopharma Inc. Major Business
Table 75. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product and Services
Table 76. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. PDRadiopharma Inc. Recent Developments/Updates
Table 78. GE Healthcare Ltd Basic Information, Manufacturing Base and Competitors
Table 79. GE Healthcare Ltd Major Business
Table 80. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product and Services
Table 81. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. GE Healthcare Ltd Recent Developments/Updates
Table 83. DOE IP Basic Information, Manufacturing Base and Competitors
Table 84. DOE IP Major Business
Table 85. DOE IP Radiopharmaceuticals for Diagnosis Product and Services
Table 86. DOE IP Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. DOE IP Recent Developments/Updates
Table 88. RadioMedix, Inc. Basic Information, Manufacturing Base and Competitors
Table 89. RadioMedix, Inc. Major Business
Table 90. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product and Services
Table 91. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. RadioMedix, Inc. Recent Developments/Updates
Table 93. Lantheus Basic Information, Manufacturing Base and Competitors
Table 94. Lantheus Major Business
Table 95. Lantheus Radiopharmaceuticals for Diagnosis Product and Services
Table 96. Lantheus Radiopharmaceuticals for Diagnosis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Lantheus Recent Developments/Updates
Table 98. Global Radiopharmaceuticals for Diagnosis Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 99. Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturer (2019-2024) & (USD Million)
Table 100. Global Radiopharmaceuticals for Diagnosis Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 101. Market Position of Manufacturers in Radiopharmaceuticals for Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 102. Head Office and Radiopharmaceuticals for Diagnosis Production Site of Key Manufacturer
Table 103. Radiopharmaceuticals for Diagnosis Market: Company Product Type Footprint
Table 104. Radiopharmaceuticals for Diagnosis Market: Company Product Application Footprint
Table 105. Radiopharmaceuticals for Diagnosis New Market Entrants and Barriers to Market Entry
Table 106. Radiopharmaceuticals for Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Radiopharmaceuticals for Diagnosis Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 108. Global Radiopharmaceuticals for Diagnosis Sales Quantity by Region (2019-2024) & (K Units)
Table 109. Global Radiopharmaceuticals for Diagnosis Sales Quantity by Region (2025-2030) & (K Units)
Table 110. Global Radiopharmaceuticals for Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Global Radiopharmaceuticals for Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 112. Global Radiopharmaceuticals for Diagnosis Average Price by Region (2019-2024) & (US$/Unit)
Table 113. Global Radiopharmaceuticals for Diagnosis Average Price by Region (2025-2030) & (US$/Unit)
Table 114. Global Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2024) & (K Units)
Table 115. Global Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2025-2030) & (K Units)
Table 116. Global Radiopharmaceuticals for Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 117. Global Radiopharmaceuticals for Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 118. Global Radiopharmaceuticals for Diagnosis Average Price by Type (2019-2024) & (US$/Unit)
Table 119. Global Radiopharmaceuticals for Diagnosis Average Price by Type (2025-2030) & (US$/Unit)
Table 120. Global Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Global Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Global Radiopharmaceuticals for Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Global Radiopharmaceuticals for Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Global Radiopharmaceuticals for Diagnosis Average Price by Application (2019-2024) & (US$/Unit)
Table 125. Global Radiopharmaceuticals for Diagnosis Average Price by Application (2025-2030) & (US$/Unit)
Table 126. North America Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2024) & (K Units)
Table 127. North America Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2025-2030) & (K Units)
Table 128. North America Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2024) & (K Units)
Table 129. North America Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2025-2030) & (K Units)
Table 130. North America Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2024) & (K Units)
Table 131. North America Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2025-2030) & (K Units)
Table 132. North America Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 133. North America Radiopharmaceuticals for Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 134. Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2024) & (K Units)
Table 135. Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2025-2030) & (K Units)
Table 136. Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2024) & (K Units)
Table 137. Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2025-2030) & (K Units)
Table 138. Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2024) & (K Units)
Table 139. Europe Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2025-2030) & (K Units)
Table 140. Europe Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 141. Europe Radiopharmaceuticals for Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2024) & (K Units)
Table 143. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2025-2030) & (K Units)
Table 144. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2024) & (K Units)
Table 145. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2025-2030) & (K Units)
Table 146. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Region (2019-2024) & (K Units)
Table 147. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity by Region (2025-2030) & (K Units)
Table 148. Asia-Pacific Radiopharmaceuticals for Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Asia-Pacific Radiopharmaceuticals for Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 150. South America Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2024) & (K Units)
Table 151. South America Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2025-2030) & (K Units)
Table 152. South America Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2024) & (K Units)
Table 153. South America Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2025-2030) & (K Units)
Table 154. South America Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2024) & (K Units)
Table 155. South America Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2025-2030) & (K Units)
Table 156. South America Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 157. South America Radiopharmaceuticals for Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 158. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2019-2024) & (K Units)
Table 159. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Type (2025-2030) & (K Units)
Table 160. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2019-2024) & (K Units)
Table 161. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Application (2025-2030) & (K Units)
Table 162. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2019-2024) & (K Units)
Table 163. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity by Country (2025-2030) & (K Units)
Table 164. Middle East & Africa Radiopharmaceuticals for Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 165. Middle East & Africa Radiopharmaceuticals for Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 166. Radiopharmaceuticals for Diagnosis Raw Material
Table 167. Key Manufacturers of Radiopharmaceuticals for Diagnosis Raw Materials
Table 168. Radiopharmaceuticals for Diagnosis Typical Distributors
Table 169. Radiopharmaceuticals for Diagnosis Typical Customers
List of Figures
Figure 1. Radiopharmaceuticals for Diagnosis Picture
Figure 2. Global Radiopharmaceuticals for Diagnosis Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type in 2023
Figure 4. Technetium 99mTc Dithiodithiocarbamate Examples
Figure 5. Technetium 99mTc Polymerized Albumin Examples
Figure 6. Technetium 99mTc Pentetate Examples
Figure 7. Strontium 89Sr Chloride Examples
Figure 8. Iodine 125I Sealed Seed Source Examples
Figure 9. Sodium Iodide 131I Examples
Figure 10. Other Examples
Figure 11. Global Radiopharmaceuticals for Diagnosis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 12. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application in 2023
Figure 13. Hospital Examples
Figure 14. Clinic Examples
Figure 15. Other Examples
Figure 16. Global Radiopharmaceuticals for Diagnosis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Radiopharmaceuticals for Diagnosis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Radiopharmaceuticals for Diagnosis Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Radiopharmaceuticals for Diagnosis Price (2019-2030) & (US$/Unit)
Figure 20. Global Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Radiopharmaceuticals for Diagnosis by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 23. Top 3 Radiopharmaceuticals for Diagnosis Manufacturer (Revenue) Market Share in 2023
Figure 24. Top 6 Radiopharmaceuticals for Diagnosis Manufacturer (Revenue) Market Share in 2023
Figure 25. Global Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Radiopharmaceuticals for Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Radiopharmaceuticals for Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Radiopharmaceuticals for Diagnosis Average Price by Type (2019-2030) & (US$/Unit)
Figure 35. Global Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2019-2030)
Figure 37. Global Radiopharmaceuticals for Diagnosis Average Price by Application (2019-2030) & (US$/Unit)
Figure 38. North America Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Radiopharmaceuticals for Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 43. Canada Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 44. Mexico Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 45. Europe Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Radiopharmaceuticals for Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 50. France Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 51. United Kingdom Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 52. Russia Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 53. Italy Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Radiopharmaceuticals for Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 58. China Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 59. Japan Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 60. South Korea Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 61. India Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 62. Southeast Asia Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 63. Australia Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 64. South America Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Radiopharmaceuticals for Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 69. Argentina Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Quantity Market Share by Country (2019-2030)
Figure 73. Middle East & Africa Radiopharmaceuticals for Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 74. Turkey Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 75. Egypt Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 77. South Africa Radiopharmaceuticals for Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 78. Radiopharmaceuticals for Diagnosis Market Drivers
Figure 79. Radiopharmaceuticals for Diagnosis Market Restraints
Figure 80. Radiopharmaceuticals for Diagnosis Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Radiopharmaceuticals for Diagnosis in 2023
Figure 83. Manufacturing Process Analysis of Radiopharmaceuticals for Diagnosis
Figure 84. Radiopharmaceuticals for Diagnosis Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Atom High-tech Co., Ltd. Shanghai Xinke Pharmaceutical Co., Ltd. Guangdong Xi'ai Pharmaceutical Co., Ltd. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Chengdu Yunke Pharmaceutical Co., Ltd. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Shenzhen Larven Bioengineering Technology Co., Ltd. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Beijing Zhibo High-tech Biotechnology Co., Ltd. Tianjin Said Biopharmaceutical Co., Ltd. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Chengdu Xinke Pharmaceutical Co., Ltd. Jubilant Radiopharma PDRadiopharma Inc. GE Healthcare Ltd DOE IP RadioMedix, Inc. Lantheus
30 Aug 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
